What Is Hypotrichosis Of Eyelashes

Originally approved for ocular hypertension treatment, Bimatoprost is now clinically approved to treat hypotrichosis of eyelashes (a condition indicated by an inadequate number of eyelashes). 

An inadequate number of eyelashes characterizes hypotrichosis of eyelashes. Lashes provide a natural protective barrier for your delicate eyes from foreign bodies, wind, sunshine, and sweat. Eyelashes work exactly as the whiskers on a mouse or a cat. They are sensitive to touch but provide a warning when a foreign object is near the eye.

In addition to their protective purpose, eyelash plays a crucial role in enhancing eye beauty. Many people consider eyelash length and thickness a part of the cosmetic attraction. Beautiful eyes with eyebrows, nose, lips, cheeks, and chin create a complete facial appearance and give everyone a unique appearance. Lack of growth or absence of lashes removes one of the salient features associated with a normal facial appearance. Since ancient times, long lashes have been considered a sign of femininity in most cultures. 

Pharmacology of Eyelash Characteristics

Eyelashes have the widest diameter of body hair and are the most pigmented.  Hair follicles follow a cycle, and the entire cycle depends on location in the body. Each eyelash lives an average of 3 to 6 months. The cycle involves a growth phase called anagen; eyelashes last approximately 30 days. The eyelash growth phase is followed by a transition stage (catagen) of 15 days, shortening the hair follicle. At the end of the cycle, the follicle enters telogen phases, also known as the resting stage of almost 100 days, leading to the eyelash’s detachment. The lash growth varies in each individual. The good thing is that our eyelashes do not turn grey with ageing or if they do turn at an extremely late stage of life. Several factors are associated with hair follicle growth, but their effects on eyelash growth are unclear.  

What are the causes of Hypotrichosis?

There are many causes of hypotrichosis of eyelashes, including ageing, hereditary, certain health conditions, chemotherapy, and other medical treatments. Physical trauma, eye surgery, and trichotillomania may cause thinning or loss of eyelashes. The USA Food and drug administration approved bimatoprost ophthalmic solution 0.03% as an eye drop to treat ocular hypertension and open-angle glaucoma.   Enhance eyelash was observed in some users as an adverse effect in a clinical trial examining the eyelash-enhancing properties of the pharmaceutical ingredient. This finding led to bimatoprost evaluations to cure reduced eyelash growth caused by several factors, including heredity: alopecia areata, physical trauma, and chemotherapy. Sometimes eyelash hypotrichosis may result from an increased risk of ocular injury. Eyelashes play a protective role in keeping small substances and irritants from the ocular surface. Lack of eyelash growth can lead to emotional distress and impairment in psychological function.

What is Bimatoprost Ophthalmic Solution?

Since the introduction of bimatoprost as an ocular hypotensive agent for glaucoma treatment, an increase in lash length and fullness has been reported as a regular phenomenon associated with the ophthalmic solution. In several clinical studies, Bimatoprost eye drops were found to have a higher eyelash growth occurrence. Later, it was clinically tested and approved for increasing eyelash length, thickness, and darkness in patients with hypotrichosis of eyelashes. In this blog, you will learn about bimatoprost’s pharmacology, efficacy, and safety in treating eyelash hypotrichosis.

Bimatoprost is like a natural chemical in the body called prostaglandin. It is effective against patients with not enough or inadequate eyelashes. The ophthalmic preparation makes the eyelashes more noticeable, causing more lashes to grow and making them longer, darker, and thicker than ever. Learning to apply this medication properly is important for the best results. Once-daily application in the evening is sufficient to induce lash-lengthening effects. To apply this ophthalmic preparation, first wash your hands and face. Make sure no makeup traces are left, and remove contact lenses (if any). One may reinsert contact lenses fifteen minutes after applying this eye drop.  Place a single drop onto the applicator brush, then draw a straight line on the upper lash line from inwards to outward.  Do not apply at the lower lash line; remove the excess solution with the help of tissue or cotton. Throw away the applicator after applying the careprost ophthalmic preparation. If this medication gets into your eyes, do not rinse your eyes. The medication is not likely to cause harm of it gets into your eyes as the kit is the same medication used in the eyes to treat glaucoma and ocular hypertension.

Conclusion

Long, luscious eyelashes are recognized as enhancing beauty features and are often desired by women. Now the options to augment eyelashes’ prominence are not limited to several coats of mascara, falsies, or extensions. Bimatoprost ophthalmic solution 0.03% Careprost eyelash serum, originally approved for ocular hypertension and glaucoma, is now approved and clinically tested for treating hypotrichosis of eyelashes. The eye drops applied once daily to the upper lash line increase eyelash growth, including length, thickness, and darkness.